Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
| Gross Profit | N/A | 6,990 | 9,290 | 7,450 | 5,840 |
| Operating Expenses | 0 | 4,960 | 4,760 | 4,750 | 4,180 |
| Operating Income | N/A | -4,960 | -4,760 | -4,750 | -4,180 |
| Pre-tax Income | 0 | -4,960 | -4,760 | -4,750 | -4,180 |
| Net Income Continuous | N/A | -4,960 | -4,760 | -4,750 | -4,180 |
| Net Income | $N/A | $-4,960 | $-4,760 | $-4,750 | $-4,180 |
| EPS Diluted Before Non-Recurring Items | -9,999.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $N/A | $-4,960 | $-1,660 | $-3,040 | $-1,580 |